First Time Loading...
K

Karolinska Development AB
STO:KDEV

Watchlist Manager
Karolinska Development AB
STO:KDEV
Watchlist
Price: 1.65 SEK -1.2% Market Closed
Updated: May 16, 2024

Wall Street
Price Targets

KDEV Price Targets Summary
Karolinska Development AB

Wall Street analysts forecast KDEV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KDEV is 4.5 SEK .

Lowest
Price Target
Not Available
Average
Price Target
4.5 SEK
173% Upside
Highest
Price Target
Not Available
Karolinska Development AB Competitors:
Price Targets
NOVN
Novartis AG
8% Upside
3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
52% Upside
002317
Guangdong Zhongsheng Pharmaceutical Co Ltd
48% Downside
FAE
Faes Farma SA
9% Upside
NGM
NGM Biopharmaceuticals Inc
8% Upside
CTLT
Catalent Inc
4% Upside
DPHARMA
Duopharma Biotech Bhd
24% Upside
530477
Vikram Thermo (India) Ltd
67% Downside

Revenue
Forecast

Revenue Estimate
Karolinska Development AB

For the last 8 years the compound annual growth rate for Karolinska Development AB's revenue is -5%. The projected CAGR for the next 3 years is 0%.

-5%
Past Growth
0%
Estimated Growth
Estimates Accuracy
10%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Karolinska Development AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Karolinska Development AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KDEV's stock price target?
Price Target
4.5 SEK

According to Wall Street analysts, the average 1-year price target for KDEV is 4.5 SEK .

What is Karolinska Development AB's Revenue forecast?
Projected CAGR
0%

For the last 8 years the compound annual growth rate for Karolinska Development AB's revenue is -5%. The projected CAGR for the next 3 years is 0%.